These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2557175)

  • 41. [Pharmacologic and therapeutic perspectives on calcium inhibitors].
    Godfraind T
    Bull Mem Acad R Med Belg; 1982; 137(12):737-53. PubMed ID: 6309312
    [No Abstract]   [Full Text] [Related]  

  • 42. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium and calcium channel blockers: basic and clinical considerations.
    Seth SD; Maulik SK; Gupta YK
    Indian J Exp Biol; 1987 Nov; 25(11):729-41. PubMed ID: 2454891
    [No Abstract]   [Full Text] [Related]  

  • 44. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The advances in contractile modulation mechanism of the cardiomyocytes and the smooth muscle cells].
    Lü J; Zang WJ; Zhang CH
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):207-11. PubMed ID: 14628464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Calcium antagonists: sites of action, pharmacological effect profile and clinical use. 1: Physiologic significance of calcium ions and mechanisms of action of calcium antagonists in the subcellular area].
    Bluth R; Langnickel R
    Z Arztl Fortbild (Jena); 1986; 80(5):191-7. PubMed ID: 2424181
    [No Abstract]   [Full Text] [Related]  

  • 48. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside.
    Borger MA; Weisel RD
    Can J Cardiol; 1999 Mar; 15(3):333-40. PubMed ID: 10202197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of calcium in the regulation of normal vascular tone and in arterial hypertension].
    Ramón de Berrazueta J
    Rev Esp Cardiol; 1999; 52 Suppl 3():25-33. PubMed ID: 10614146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Calcium antagonists--determination of current status and therapeutic significance].
    Regenthal R; Voigt H; Preiss R
    Z Gesamte Inn Med; 1992 Dec; 47(12):573-82. PubMed ID: 1283652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium-antagonist drugs.
    Abernethy DR; Schwartz JB
    N Engl J Med; 1999 Nov; 341(19):1447-57. PubMed ID: 10547409
    [No Abstract]   [Full Text] [Related]  

  • 53. Calcium channels in the brain as targets for the calcium-channel modulators used in the treatment of neurological disorders.
    Peters T; Wilffert B; Vanhoutte PM; van Zwieten PA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S1-5. PubMed ID: 1726728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A symposium: The calcium ion, cardiac myocyte and vascular smooth muscle in hypertension and its treatment. March 27-29, Nassau, the Bahamas.
    Am J Cardiol; 1987 Jan; 59(2):1A-121A. PubMed ID: 2433924
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium, vascular smooth muscle, and calcium entry blockers in hypertension.
    Cohn JN
    Ann Intern Med; 1983 May; 98(5 Pt 2):806-9. PubMed ID: 6847019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Calcium, calcium antagonists and cerebral circulation].
    Beketov AI; Gromova TM
    Farmakol Toksikol; 1988; 51(2):103-7. PubMed ID: 2454201
    [No Abstract]   [Full Text] [Related]  

  • 57. Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification).
    Godfraind T
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():5-30. PubMed ID: 2424268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanism of action of calcium antagonists].
    Stimpel M; Neyses L
    Schweiz Rundsch Med Prax; 1985 May; 74(19):483-90. PubMed ID: 2409579
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanism of action of calcium antagonists in the treatment of vascular diseases].
    Mayerhofer S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of calcium channel blockers in clinical medicine.
    Urthaler F
    Am J Med Sci; 1986 Oct; 292(4):217-30. PubMed ID: 2428245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.